Atossa Therapeutics
ATOS
#10437
Rank
โ‚ฌ4.09 M
Marketcap
0,48ย โ‚ฌ
Share price
-5.83%
Change (1 day)
-42.62%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚ฌ26.87 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.49 Million, an increase over its 2023 earnings that were of -โ‚ฌ25.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ26.87 Million25.02%
2024 -โ‚ฌ21.49 Million-15.25%
2023 -โ‚ฌ25.36 Million11.62%
2022 -โ‚ฌ22.72 Million30.84%
2021 -โ‚ฌ17.36 Million15.58%
2020 -โ‚ฌ15.02 Million3.41%
2019 -โ‚ฌ14.53 Million51.16%
2018 -โ‚ฌ9.61 Million40.41%
2017 -โ‚ฌ6.85 Million27.54%
2016 -โ‚ฌ5.37 Million-47.49%
2015 -โ‚ฌ10.22 Million-17.25%
2014 -โ‚ฌ12.35 Million35.91%
2013 -โ‚ฌ9.09 Million112.3%
2012 -โ‚ฌ4.28 Million46.53%
2011 -โ‚ฌ2.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.29 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.08 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.12 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ35.11 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ92.01 Million 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.61 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA